跳至主要内容
临床试验/ITMCTR2000003308
ITMCTR2000003308招募中未知

The clinical and neuromechanisms research for Shizhen Anshen granules treatment on cognitive impairments of first episode schizophrenia

Beijing Anding Hospital, Capital Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 40(—)
性别
All

入选标准

  • 1. Patients who meet the criteria of first-episode schizophrenia stipulated in the study;
  • 2. Patients aged 18-40 (including 18 and 40 years old);
  • 3. Patients who voluntarily sign the informed consent and are able to follow the research program;
  • 4. Patients who can understand the follow-up questionnaire;
  • 5. Patients who meet the criteria of syndrome type of kidney yin deficiency and fire hyperactivity of TCM in psychiatry (hallucination, delusion, weird thinking, scattered thinking, dull and little speech, self talk and self laugh, alone in a corner, sore waist and knees, dry mouth, constipation, red tongue, little moss, teeth marks, fine pulse strings).

排除标准

  • 1. Objects with serious suicidal tendencies;
  • 2. Patients with depressive episode;
  • 3. Patients with serious or unstable heart, liver, kidney, endocrine, blood and other medical diseases;
  • 4. The patients who took antipsychotic drugs in the first 4 weeks were selected;
  • 5. Patients without supervision;
  • 6. Patients with PANSS score reduction rate >= 25% at baseline compared with those at screening.

研究者

相似试验